WuXi, which previously backed Adagene's $8m series A round, returned for the antibody developer's latest round alongside two Fidelity Investments subsidiaries.

Nomura has partnered Keio University to raise an $84m fund aimed at startups in sectors such as space technology, life sciences and regenerative medicine.

Cancer treatment developer Blend Therapeutics has now raised almost $78m altogether and has changed its name to Tarveda Therapeutics.

Joincare Pharmaceutical acquired a 14.9% stake in Apricot Forest as part of a series D round that will value the physician information app at $200m.

Immunotherapy developer Adicet Bio revealed the series A funding alongside its acquisition of Israel-based Applied Immune Technologies.

Brainlab, which had provided neurological diagnostics tool developer Jan Medical with series B funding, has invested another $7.5m.

Healthcare R&D company PureTech Health, which co-founded Akili Interactive Labs, has participated in a $30.5m round for the digital medicine company.

Johnson and Johnson reinvested in Inivata, which will use the series A funding to advance its cancer diagnostics platform through clinical studies.